Kolexia
Schleiermacher Gudrun Pédiatrie
Schleiermacher Gudrun
Pédiatrie
Clcc Institut Curie
Paris, France
217 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Neuroblastome Récidive tumorale locale Aberrations des chromosomes Tumeur de Wilms Tumeurs du rein Prédisposition génétique à une maladie Rhabdomyosarcome Tumeurs osseuses Sarcomes

Collaborateurs

Voir plus
Delattre Olivier
Delattre Olivier
Clcc Institut Curie, Paris, France
Valteau-Couanet Dominique
Valteau-Couanet Dominique
Gustave-Roussy, Villejuif, France
Michon Jean
Michon Jean
Clcc Institut Curie, Paris, France
Geoerger Birgit
Geoerger Birgit
Gustave-Roussy, Villejuif, France

Industries

Voir plus
BMS
2 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
European journal of cancer (Oxford, England : 1990)   15 février 2024
NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)
Essai Clinique (New Approaches to Neuroblastoma Therapy Consortium)   07 février 2024
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies: INFORM2 Exploratory Multinational Phase I/II Combination Study of Nivolumab and Entinostat in Children and Adolescents With Refractory High-risk Malignancies (INFORM2-NivEnt)
Essai Clinique (University Hospital Heidelberg)   05 février 2024
MICCHADO: Molecular and Immunological Characterisation of High Risk CHildhood Cancer At DiagnOsis, Treatment and Follow-up - Biological Evaluation in Children, Adolescents and Young Adults -
Essai Clinique (Institut Curie)   02 février 2024
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common and transcriptional silencing across advanced pediatric solid cancers.
Frontiers in immunology   22 janvier 2024
Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript.
The British journal of radiology   16 janvier 2024
Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives.
JCO precision oncology   15 janvier 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   08 janvier 2024
BIOPORTAL: SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
Essai Clinique (Institut Curie)   06 novembre 2023
HIGH RISK NEUROBLASTOMA (HR-NB) WITH MNA AND AGE
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023